ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The results showed, 51.21% (21/41) CML patients had no appreciable change in the expression of BCR-ABL gene and 48.78% (20/41) patients showed significant fall in the expression of BCR-abl gene (Fig. 2a,b).